Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantationOriginal Research Published on 2021-02-082023-06-09 Journal: Immunity, Inflammation and Disease [Category] E형 간염, [키워드] Chronic HEV infection ELISPOT ribavirin rituximab serial HEV RNA monitoring SOT [DOI] 10.1002/iid3.411 PMC 바로가기 [Article Type] Original Research
A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapyarticle Published on 2021-02-032024-09-02 Journal: Kidney International Reports [Category] 대상포진, [키워드] B-cell depletion therapy lupus nephritis rituximab systemic lupus erythematosus [DOI] 10.1016/j.ekir.2021.01.027 PMC 바로가기 [Article Type] article
COVİD-19 infection in a membranous nephropathy patient treated with rituximab리툭시맙으로 치료받은 막성 신병증 환자의 COVİD-19 감염Case Reports Published on 2021-02-012022-09-11 Journal: CEN case reports [Category] MERS, SARS, 진단, 치료제, [키워드] accumulation Administered Affect approach caused change chronic disease Chronic diseases contribute coronavirus country COVID-19 COVID-19 pandemic diagnosis of COVID-19 Follow-up healthcare Immunosuppression immunosuppressive immunosuppressive therapy Infection knowledge life Membranous nephropathy nephropathy nephrotic syndrome pandemic Patient rituximab syndrome therapy treat treated Treatment while [DOI] 10.1007/s13730-020-00524-3 PMC 바로가기 [Article Type] Case Reports
The impact of COVID-19 pandemic on patients with ANCA associated vasculitisANCA 관련 혈관염 환자에 대한 COVID-19 범유행의 영향Article Published on 2021-02-012022-09-12 Journal: Journal of Nephrology [Category] MERS, 진단, [키워드] acute respiratory syndrome age appear Care changes in Characteristics conducted Contact coronavirus Coronavirus 2019 COVID-19 COVID-19 infection COVID-19 pandemic cross-sectional demographics disease female General population Health Immunosuppression in-person visit incidence incidence of COVID-19 increased risk indicated individual kidney lung majority pandemic Patient patient population patients PCR positive receiving risk risk of COVID-19 rituximab SARS CoV-2 Surveillance susceptible Symptom telemedicine consultation tested the median therapy Vasculitis [DOI] 10.1007/s40620-020-00881-3 PMC 바로가기 [Article Type] Article
Hepatitis B Virus Reactivation 55 Months Following Chemotherapy Including Rituximab and Autologous Peripheral Blood Stem Cell Transplantation for Malignant LymphomaCase Reports Published on 2021-02-012023-06-13 Journal: Internal medicine (Tokyo, Japan) [Category] B형 간염, [키워드] de novo hepatitis Hepatitis B virus reactivation peripheral blood stem cell transplantation rituximab [DOI] 10.2169/internalmedicine.5678-20 PMC 바로가기 [Article Type] Case Reports
Rituximab for the treatment of multiple sclerosis: a reviewReview Published on 2021-01-082024-09-04 Journal: Journal of Neurology [Category] 대상포진, [키워드] Efficacy multiple sclerosis rituximab Safety [DOI] 10.1007/s00415-020-10362-z PMC 바로가기 [Article Type] Review
Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumoniaComment Published on 2021-01-012023-07-14 Journal: Annals of the rheumatic diseases [Category] SARS, [키워드] communicable diseases, imported Granulomatosis with polyangiitis Hydroxychloroquine rituximab systemic vasculitis [DOI] 10.1136/annrheumdis-2020-217549 [Article Type] Comment
Discrepant Antigen-specific Antibody Responses Causing SARS-CoV-2 Persistence in a Patient Receiving B-cell-targeted Therapy with Rituximab리툭시맙으로 B 세포 표적 치료를 받는 환자에서 SARS-CoV-2 지속성을 유발하는 불일치 항원 특이적 항체 반응Case Reports Published on 2021-01-012022-09-11 Journal: Internal medicine (Tokyo, Japan) [Category] MERS, 진단, 치료기술, 치료법, 치료제, [키워드] antibody Antibody Response B-cell causing clearance comparable COVID-19 highlight humoral immune response humoral immune responses immune responses Kinetics Lymphoid tissue lymphoma magnitude MONITOR mucosa-associated lymphoid tissue Neutralizing Neutralizing activity Neutralizing antibody response persistent RNAemia Pneumonia recipient recipients remained response rituximab SARS-CoV-2 SARS-COV-2 infection serological suffered therapy titer treated unique Viral [DOI] 10.2169/internalmedicine.7884-21 PMC 바로가기 [Article Type] Case Reports
Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: ‘Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia’ by Guilpain et alComment Published on 2021-01-012023-07-14 Journal: Annals of the rheumatic diseases [Category] SARS, [키워드] Autoimmunity rituximab systemic vasculitis [DOI] 10.1136/annrheumdis-2020-217555 [Article Type] Comment
Rituximab as the treatment of pemphigus vulgaris in the COVID-19 pandemic era: A narrative reviewCOVID-19 대유행 시대의 심상성 천포창 치료제로서의 리툭시맙: 내러티브 리뷰Review Published on 2021-01-012022-09-12 Journal: Dermatologic therapy [Category] MERS, SARS, 진단, [키워드] adverse effect adverse outcomes anti-CD20 anti-CD20 therapy article Autoimmune blistering clinical study COVID-19 COVID-19 pandemic database disease drugs Evidence immunosuppressive immunosuppressive medications novel coronavirus disease pandemic Patient patients patients with COVID-19 pemphigus pemphigus vulgaris performed raised reported rituximab searched Seven shown therapy treated Treatment website [DOI] 10.1111/dth.14405 PMC 바로가기 [Article Type] Review